Concert Pharmaceuticals Inc CNCE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:58 AM EDT
2.68quote price arrow down-0.01 (-0.37%)
Volume
32,541
52 week range
2.64 - 13.50
Loading...
  • Open2.68
  • Day High2.70
  • Day Low2.67
  • Prev Close2.69
  • 52 Week High13.50
  • 52 Week High Date12/11/20
  • 52 Week Low2.64
  • 52 Week Low Date10/26/21

Key Stats

  • Market Cap86.22M
  • Shares Out32.17M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-78.81

KEY STATS

  • Open2.68
  • Day High2.70
  • Day Low2.67
  • Prev Close2.69
  • 52 Week High13.50
  • 52 Week High Date12/11/20
  • 52 Week Low2.64
  • 52 Week Low Date10/26/21
  • Market Cap86.22M
  • Shares Out32.17M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-78.81

RATIOS/PROFITABILITY

  • EPS (TTM)-1.79
  • P/E (TTM)-1.49
  • Fwd P/E (NTM)-0.76
  • EBITDA (TTM)-57.04M
  • ROE (TTM)-43.88%
  • Revenue (TTM)33.53M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-174.60%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Concert Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others. The Company's deuterated chemical entity platform (DCE Platform), has potential across various therapeutic areas. Its product candidates include AVP-786, CTP-656, CTP-730, CTP-543 and JZP-386. The...
Richard Aldrich
Non-Executive Chairman
Roger Tung Ph.D.
President
Nancy Stuart
Chief Operating Officer
Marc Becker CPA
Chief Financial Officer
Address
65 Hayden Ave Ste 3000N
Lexington, MA
02421-7994
United States

Top Peers

SYMBOLLASTCHG%CHG
XERS
Xeris Biopharma Holdings Inc
1.83UNCHUNCH
CDTX
Cidara Therapeutics Inc
1.54UNCHUNCH
ENVB
Enveric Biosciences Inc
1.70+0.05+3.03%
ORGS
Orgenesis Inc
4.85+0.09+1.89%
PLX
Protalix Biotherapeutics Inc
1.12+0.01+0.45%